Crosstree

Crosstree’s latest Weekly Transactional Report (Week of April 13, 2025) highlights continued activity in the health sciences sector, with notable trends in both financing and M&A: - Highlight transactions include: 📌Cedar Park Health System, L.P. acquired by Ascension Texas 📌iCad acquired by RadNet Inc. 📌Solaborate (https://hubs.li/Q03jwzcW0) raised $47M in funding led by HealthQuest Capital This week saw a notable increase in M&A activity, particularly with strategic acquisitions in the clinical services and health system sectors. These transactions reflect the continued consolidation in the healthcare space, with companies seeking to expand their capabilities and drive growth. At the same time, ongoing investment in eClinical solutions and innovative technologies (particularly related to AI) demonstrates the industry's commitment to enhancing operational efficiency and improving patient outcomes. Whether you are an owner/operator in the health sciences or a private equity professional operating the space, our industry insights and reports have the data you need stay on top of relevant trends in the industry. Subscribe to Crosstree insights at: https://hubs.li/Q03jwHRV0 If you want to connect with a senior member of our banking team, drop us a note at the link below: https://hubs.li/Q03jwKmb0 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews #PharmaServices

Are you attending this year's Executive War College in New Orleans? Join Crosstree's Jeff Ellis, Managing Director and Co-Founder, for a panel discussion on Business and Marketing Strategies for Laboratories in Changing Times on Tuesday, April 29th, at 1:30 PM. Click the link to view the full EWC agenda: https://hubs.li/Q03hP4VL0 We look forward to seeing you there! #EWC #EWC2025 #ClinicalResearch #investmentbanking #privateequity

Crosstree’s latest Weekly Transactional Report (Week of April 6, 2025) highlights continued activity in the health sciences sector, with notable trends in both financing and M&A: - Highlight transactions include: 📌Rocket Doctor acquired by Treatment AI 📌VitalHub UK Limited acquired Induction Healthcare Group 📌Curium SAS invested in NUCLEIS SA While M&A activity was modest this week, the sustained financing activity—particularly in eClinical and clinical services sectors—underscores the continued demand for innovation and efficiency in the pharmaceutical and biotechnology industries. This ongoing investment highlights the strategic importance of leveraging advanced technologies and services to drive the growth and success of clinical trials in an increasingly complex market. Whether you are an owner/operator in the health sciences or a private equity professional operating the space, our industry insights and reports have the data you need stay on top of relevant trends in the industry. Subscribe to Crosstree insights at: https://hubs.li/Q03hCJm60 If you want to connect with a senior member of our banking team, drop us a note at the link below: https://hubs.li/Q03hCWxD0 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews #PharmaServices

As the frequency and severity of data breaches has increased, so have the costs to health systems whose operations are disrupted by system outages. These events – such as the major cyberattacks on Ascension and CommonSpirit, major health systems each with over 140 hospitals – jeopardize patient care and safety. By joining RLDatix a global leader in safety, workforce and data solutions for healthcare systems, IPeople Healthcare, an RLDatix company will strengthen its ability to deliver scalable, cost-effective solutions for downtime management, data extraction, and compliance, supporting continuity of care in an evolving digital landscape. Crosstree acted as the exclusive financial advisor to IPeople in this transaction. Read more about this #acquisition in our Deal Insights: https://hubs.li/Q03hqkjC0 #healthcareinnovation #hcit #healthit #interoperability #mergersandacquisitions #investmentbanking Benjamin J. Garber

The March 2025 edition of our Pharma Services: Drug Development BlueBook is now available. Read why C-suite executives and private equity professionals in the health sciences industries turn to our publication for valuation trends, M&A activity, and transaction reporting. Here's a glimpse into the March 2025 edition: 📌Clinilabs was acquired by InTandem Capital Partners 📌Kardigan announced its acquisition of Prolaio 📌Mendel.ai closed a $35MM Series B Financing, led by Industry Ventures, BECO Capital, Hi Ventures, Base10 Partners, PayPal Ventures and Infinity Ventures Download the full March edition now: https://hubs.li/Q03hd1r-0 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews

Crosstree’s latest Weekly Transactional Report (Week of March 30, 2025) highlights continued activity in the health sciences sector, with notable trends in both financing and M&A: - Over $1.8M in financing volume across 8 deals - Highlight transactions include: 📌 United Wound and Skin Solutions, LLC raised $7.65M 📌 Artis BioSolutions acquired by Morris & Dickinson 📌 Ubie forms a strategic business alliance with Seven-Eleven Japan 📌Cherry Labs received $0.1M in funding from Boba Mint Holdings Ltd. While M&A activity saw a small uptick this week, the ongoing financing activity—particularly in sectors like eClinical and lab services—highlights the continued strategic importance of data-driven drug development. This sustained financing reflects the increasing demand for innovation and adaptability in clinical trials and drug development processes. Whether you are an owner/operator in the health sciences or a private equity professional operating the space, our industry insights and reports have the data you need stay on top of relevant trends in the industry. Subscribe to Crosstree insights at: https://hubs.li/Q03g_1rG0 If you want to connect with a senior member of our banking team, drop us a note at the link below: https://hubs.li/Q03g_1dz0 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews #PharmaServices

In the complex and fast-evolving Pharma Services sector, having the right advisor makes all the difference. At Crosstree, we bring unparalleled expertise, deep industry relationships, and a track record of success in M&A, capital raising, and strategic advisory. Whether you're in discovery, preclinical, clinical development, or commercialization, our team helps navigate the evolving landscape of precision and specialty medicine, delivering tailored solutions for growth and transaction support. Connect with us to learn how Crosstree Capital can support your next strategic move: https://hubs.li/Q03gggLM0 #PharmaServices #MergersAndAcquisitions #PrivateEquity #InvestmentBanking

Crosstree’s latest Weekly Transactional Report (Week of March 23, 2025) reveals a clear signal: investor appetite for eClinical and lab services remains robust. - Over $286M in financing volume across 10 deals - Highlight transactions include: 📌 Navina raised $55M led by Goldman Sachs 📌 Mendel secured $35M Series B led by Base10 Partners 📌 Xealth received growth capital from Morningside Ventures 📌MindBio acquired Life AI Corp While M&A volume was modest this week, the sustained financing activity—especially in data-driven drug development enablement—underscores the strategic urgency across the ecosystem. Whether you are an owner/operator in the health sciences or a private equity professional operating the space, our industry insights and reports have the data you need stay on top of relevant trends in the industry. Subscribe to Crosstree insights at: https://hubs.li/Q03fQgW90 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews #PharmaServices

The February 2025 edition of our Pharma Services - Drug Supply Chain BlueBook is now available! Whether you're exploring emerging trends or planning your next big move in health sciences, the updated BlueBook format ensures the information is more accessible and impactful than ever before. Highlights from this edition include: 📌 Pii, A Jabil Company was acquired by Jabil 📌 Ionic Partners announced its acquisition of Connexion Technologies 📌 Avelios Medical closed a $31MM Series A Financing, led by Sequoia Capital, HTGF | High-Tech Gründerfonds and Revent Want to read more? Click the link below: https://hubs.li/Q03f99Nl0 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews #PharmaServices

The pharma services industry is rapidly evolving with AI-driven patient recruitment transforming clinical trials by accelerating enrollment and improving trial efficiency. The acquisition of Deep 6 AI by Tempus AI leverages the strengths of both companies to enhance patient recruitment and qualification for clinical trials. By integrating Deep 6's AI and natural language processing technology, Tempus has improved their ability to access and analyze unstructured data, including physician notes, to better match patients with clinical trial criteria. Crosstree acted as a financial advisor to Deep 6 in this transaction. Read more about this #acquisition in our Deal Insights: https://hubs.li/Q03d7Q4k0 #pharmaAI #pharma #mergersandacquisitions #investmentbanking Shane Senior